All SEC Filings :: Ligand Pharmaceuticals Incorporated (LGND)

Filter Filings:

Date	Form	Description	Docs	XBRL	Pages
03/01/22	4	Statement of changes in beneficial ownership of securities			2
02/28/22	10-K	Annual report pursuant to Section 13 and 15(d) Related Documents EX-10.37 EX-10.39 EX-21.1 EX-23.1 EX-31.1 EX-31.2 EX-32.1			274
02/17/22	8-K	Current report filing Related Documents EX-99.1			15
02/16/22	4	Statement of changes in beneficial ownership of securities			2
02/16/22	4	Statement of changes in beneficial ownership of securities			2
02/16/22	4	Statement of changes in beneficial ownership of securities			2
02/16/22	4	Statement of changes in beneficial ownership of securities			2
02/14/22	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			12
02/14/22	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			4
02/11/22	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			1